Literature DB >> 19109254

SDF2L1, a component of the endoplasmic reticulum chaperone complex, differentially interacts with {alpha}-, {beta}-, and {theta}-defensin propeptides.

Prasad Tongaonkar1, Michael E Selsted.   

Abstract

Mammalian defensins are cationic antimicrobial peptides that play a central role in host innate immunity and as regulators of acquired immunity. In animals, three structural defensin subfamilies, designated as alpha, beta, and , have been characterized, each possessing a distinctive tridisulfide motif. Mature alpha- and beta-defensins are produced by simple proteolytic processing of their prepropeptide precursors. In contrast, the macrocyclic -defensins are formed by the head-to-tail splicing of nonapeptides excised from a pair of prepropeptide precursors. Thus, elucidation of the -defensin biosynthetic pathway provides an opportunity to identify novel factors involved in this unique process. We incorporated the -defensin precursor, proRTD1a, into a bait construct for a yeast two-hybrid screen that identified rhesus macaque stromal cell-derived factor 2-like protein 1 (SDF2L1), as an interactor. SDF2L1 is a component of the endoplasmic reticulum (ER) chaperone complex, which we found to also interact with alpha- and beta-defensins. However, analysis of the SDF2L1 domain requirements for binding of representative alpha-, beta-, and -defensins revealed that alpha- and beta-defensins bind SDF2L1 similarly, but differently from the interactions that mediate binding of SDF2L1 to pro--defensins. Thus, SDF2L1 is a factor involved in processing and/or sorting of all three defensin subfamilies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109254      PMCID: PMC2645818          DOI: 10.1074/jbc.M806664200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils.

Authors:  O Chertov; D F Michiel; L Xu; J M Wang; K Tani; W J Murphy; D L Longo; D D Taub; J J Oppenheim
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

2.  A rapid method combining a functional test of fusion proteins in vivo and their purification.

Authors:  C Baniahmad; A Baniahmad; B W O'Malley
Journal:  Biotechniques       Date:  1994-02       Impact factor: 1.993

3.  Several endoplasmic reticulum stress proteins, including ERp72, interact with thyroglobulin during its maturation.

Authors:  G Kuznetsov; L B Chen; S K Nigam
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

4.  Direct inactivation of viruses by human granulocyte defensins.

Authors:  K A Daher; M E Selsted; R I Lehrer
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

5.  Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor.

Authors:  F Yoshikawa; M Morita; T Monkawa; T Michikawa; T Furuichi; K Mikoshiba
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

6.  Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides.

Authors:  S B Aley; M Zimmerman; M Hetsko; M E Selsted; F D Gillin
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Posttranslational processing of defensins in immature human myeloid cells.

Authors:  E V Valore; T Ganz
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

8.  Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.

Authors:  S Herwig; Q Su; W Zhang; Y Ma; P Tempst
Journal:  Blood       Date:  1996-01-01       Impact factor: 22.113

9.  The pro region of human neutrophil defensin contains a motif that is essential for normal subcellular sorting.

Authors:  L Liu; T Ganz
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

10.  Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores.

Authors:  W C Wimley; M E Selsted; S H White
Journal:  Protein Sci       Date:  1994-09       Impact factor: 6.725

View more
  6 in total

1.  Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance.

Authors:  Sachel Mok; Elizabeth A Ashley; Pedro E Ferreira; Lei Zhu; Zhaoting Lin; Tomas Yeo; Kesinee Chotivanich; Mallika Imwong; Sasithon Pukrittayakamee; Mehul Dhorda; Chea Nguon; Pharath Lim; Chanaki Amaratunga; Seila Suon; Tran Tinh Hien; Ye Htut; M Abul Faiz; Marie A Onyamboko; Mayfong Mayxay; Paul N Newton; Rupam Tripura; Charles J Woodrow; Olivo Miotto; Dominic P Kwiatkowski; François Nosten; Nicholas P J Day; Peter R Preiser; Nicholas J White; Arjen M Dondorp; Rick M Fairhurst; Zbynek Bozdech
Journal:  Science       Date:  2014-12-11       Impact factor: 47.728

Review 2.  HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.

Authors:  Alexander M Cole; Amy L Cole
Journal:  Viruses       Date:  2017-05-15       Impact factor: 5.048

3.  Identification of Phosphorylated Proteins Regulated by SDF2L1 in Nasopharyngeal Carcinoma Cells.

Authors:  Chengchang Luo; Zunni Zhang; Qisheng Su; Wuning Mo
Journal:  Evol Bioinform Online       Date:  2022-04-28       Impact factor: 1.625

4.  Comparative Proteomic Analysis of Liver Tissues and Serum in db/db Mice.

Authors:  Yu Zhang; Xiumei Wu; Mengyun Xu; Tong Yue; Ping Ling; Tingyu Fang; Sihui Luo; Suowen Xu; Jianping Weng
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

5.  A multi-platform draft de novo genome assembly and comparative analysis for the Scarlet Macaw (Ara macao).

Authors:  Christopher M Seabury; Scot E Dowd; Paul M Seabury; Terje Raudsepp; Donald J Brightsmith; Poul Liboriussen; Yvette Halley; Colleen A Fisher; Elaine Owens; Ganesh Viswanathan; Ian R Tizard
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

Review 6.  The chemistry and biology of theta defensins.

Authors:  Anne C Conibear; David J Craik
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-30       Impact factor: 15.336

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.